Advertisement
Screener

EyePoint, Inc. (EYPT) Debt / Equity

EyePoint, Inc. Debt/Equity Ratio

The debt/equity ratio shows how much a company has borrowed for every dollar its shareholders have put in. It is long-term debt, both the part due within a year and the rest, divided by shareholder equity, shown as a multiple with both amounts in the table. A higher ratio means the company relies more on borrowed money than on shareholder capital. Because equity shrinks through buybacks or losses, the ratio can rise even when debt is unchanged, and it has no meaning when equity is negative. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.

  • EyePoint, Inc. debt/equity ratio for the quarter ending 2023-09-30 was 0, a 100.00% decline year-over-year.
  • EyePoint, Inc. debt/equity ratio for the quarter ending 2023-06-30 was 0, a 100.00% decline year-over-year.
  • EyePoint, Inc. debt/equity ratio for the quarter ending 2023-03-31 was 0.44, a 86.37% increase year-over-year.
  • EyePoint, Inc. debt/equity ratio for the quarter ending 2022-12-31 was 0.41, a 108.20% increase year-over-year.
  • EyePoint, Inc. debt/equity ratio for fiscal 2022 was 0.41, a 108.20% increase from fiscal 2021.
  • EyePoint, Inc. debt/equity ratio for fiscal 2021 was 0.2.
Available history
2021-12-31 to 2023-09-30
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity RatioLong-term debtShareholder equity
2023-09-300$0.00$58.62M
2023-06-300$0.00$57.26M
2023-03-310.44$34.67M$78.39M
2022-12-310.41$39.79M$96.37M
2022-09-300.29$39.73M$136.35M
2022-06-300.26$39.66M$151.37M
2022-03-310.24$39.58M$166.82M
2021-12-310.2$36.56M$184.38M

Annual Debt/Equity Ratio

DateDebt/Equity RatioLong-term debtShareholder equity
2022-12-310.41$39.79M$96.37M
2021-12-310.2$36.56M$184.38M

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
Quanterix Corp (QTRX)United States$0.150B-1.65
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15